Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease
Sponsor: Tokyo Medical and Dental University
This PHASE3 trial investigates Crohn Disease and is currently ongoing. Tokyo Medical and Dental University leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Unknown PHASE3
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Jan 2026 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
Status: Unknown Status → Active Not Recruiting
-
Oct 2021 — Dec 2023 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
May 2019 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Unknown Status → Recruiting
-
Apr 2019 — May 2019 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Feb 2017 — Apr 2019 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tokyo Medical and Dental University
For direct contact, visit the study record on ClinicalTrials.gov .